Related Experiment Video
Updated: Aug 4, 2026
10:27
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Interstitial granulomatous dermatitis with plaques and arthritis
U Wollina1, J Schönlebe, L Unger
1Hospital Dresden-Friedrichstadt, Dresden, Germany. Wollina-Uw@khdf.de
Clinical Rheumatology
|October 28, 2003
Summary
Interstitial granulomatous dermatitis and arthritis (IGDA) is a rare condition. Cyclosporin A effectively treated a patient, clearing skin lesions and improving joint pain.
Area of Science:
- Rheumatology
- Dermatology
- Immunodermatology
Background:
- Interstitial granulomatous dermatitis and arthritis (IGDA) is a rare immune-mediated condition.
- It is characterized by skin lesions and joint inflammation, predominantly affecting women.
Observation:
- A case study of a 53-year-old woman presenting with erythemas, plaques, and nodules was documented.
- The patient also experienced polyarthritis, a key feature of IGDA.
Findings:
- Treatment with cyclosporin A led to significant improvement in the patient's joint affliction.
- Complete clearance of the patient's skin lesions was observed following cyclosporin A therapy.
Implications:
- This case highlights cyclosporin A as a potential effective treatment for IGDA.
- Further research into IGDA pathogenesis and treatment options is warranted.
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:29Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...